1
Epple Robert, Cow Christopher, Xie Yongping, Wang Xing, Russo Ross, Azimioara Mihai, Saez Enrique: Compounds and compositions as ppar modulators. Irm, Epple Robert, Cow Christopher, Xie Yongping, Wang Xing, Russo Ross, Azimioara Mihai, Saez Enrique, REID Scott W, December 8, 2005: WO/2005/116000 (54 worldwide citation)

The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of the Peroxisome Proliferator-Activated Receptor (PPAR) families, particularly the activity of PPAR.


2
Ren Pingda, Wang Xia, Jiang Songchun, Nagle Advait, Okram Barun, He Yun, Xie Yongping, Wang Xing, Huang Shenlin, Wang Xiaodong, Liu Yi, Albaugh Pamela A, Gray Nathanael S, Zhang Guobao: Protein kinase inhibitors and methods for using thereof. Irm, Ren Pingda, Wang Xia, Jiang Songchun, Nagle Advait, Okram Barun, He Yun, Xie Yongping, Wang Xing, Huang Shenlin, Wang Xiaodong, Liu Yi, Albaugh Pamela A, Gray Nathanael S, Zhang Guobao, RAYMOND Daniel E, November 27, 2008: WO/2008/144253 (43 worldwide citation)

The invention provides compounds of formula (l) and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, and methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments, the i ...


3
Ding Qiang, Xie Yongping, Gray Nathanael Schiander, You Shuli, Chopiuk Greg, Jiang Jiqing, Liu Yi, Steensma Ruo, Wang Xing, Sim Taebo: Compounds and compositions as protein kinase inhibitors. Irm, Ding Qiang, Xie Yongping, Gray Nathanael Schiander, You Shuli, Chopiuk Greg, Jiang Jiqing, Liu Yi, Steensma Ruo, Wang Xing, Sim Taebo, REID Scott W, April 21, 2005: WO/2005/034869 (33 worldwide citation)

The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal act ...


4
Ren Pingda, Zhang Guobao, You Shuli, Sim Taebo, Gray Nathanael, Xie Yongping, Wang Xing, He Yun: Compositions and methods for fgf receptor kinases inhibitors. Irm, Ren Pingda, Zhang Guobao, You Shuli, Sim Taebo, Gray Nathanael, Xie Yongping, Wang Xing, He Yun, SMITH Timothy L, November 29, 2007: WO/2007/136465 (33 worldwide citation)

Described are compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat or prevent disease or disordered associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activity of kinases such as ...


5
Huang Shenlin, Liu Zuosheng, Albaugh Pamela A, Wang Xing, Pan Shifeng, Xie Yongping, Zhang Guobao: Protein kinase inhibitors and methods for using thereof. Irm, Huang Shenlin, Liu Zuosheng, Albaugh Pamela A, Wang Xing, Pan Shifeng, Xie Yongping, Zhang Guobao, TONGO WU Emily, December 24, 2008: WO/2008/157131 (27 worldwide citation)

The invention provides compounds and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, and methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments, the invention provid ...


6
Pan Shifeng, Marsilje Thomas H, Lu Wenshuo, Gao Wenqi, Gray Nathanael Schiander, He Yun, Liu Yahua, Mi Yuan, Xie Yongping: Immunosuppressant compounds and compositions. Irm, Pan Shifeng, Marsilje Thomas H, Lu Wenshuo, Gao Wenqi, Gray Nathanael Schiander, He Yun, Liu Yahua, Mi Yuan, Xie Yongping, REID Scott W, September 9, 2005: WO/2005/082089 (24 worldwide citation)

The present invention relates to immunosuppressant, process for their production, their uses and pharmaceutical compositions containing them. The invention provides a novel class of compounds useful in the treatment or prevention of diseases or disorders mediated by lymphocyte interactions, particul ...


7
Albaugh Pamela A, He Yun, Jiang Songchun, Ren Pingda, Wang Xia, Wang Xing, Xie Yongping: [4,5]bipyrimidinyl-6,4-diamine derivatives as protein kinase inhbitors. Irm, Albaugh Pamela A, He Yun, Jiang Songchun, Ren Pingda, Wang Xia, Wang Xing, Xie Yongping, MCNALLY Lydia T, January 17, 2008: WO/2008/008747 (17 worldwide citation)

The invention provides a novel class of compounds of the Formula (I): in which the symbols have the meanings given in the description and claims, to pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abn ...


8
Sim Taebo, Nguyen Truc Ngoc, Wu Baogen, He Yun, Xie Yongping, Wang Xing, Zhang Guobao, Gray Nathanael S: Protein kinase inhibitors and methods for using thereof. Irm, Sim Taebo, Nguyen Truc Ngoc, Wu Baogen, He Yun, Xie Yongping, Wang Xing, Zhang Guobao, Gray Nathanael S, TONGCO WU Emily, December 24, 2008: WO/2008/157575 (15 worldwide citation)

The invention provides compounds and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, and methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments, the invention provid ...


9
Ren Pingda, Wu Baogen, Zhang Guobao, Xie Yongping, Okram Barun, Nikulin Victor, Wang Xia, Choi Ha Soon: Compounds and compositions as protein kinase inhibitors. Irm, Ren Pingda, Wu Baogen, Zhang Guobao, Xie Yongping, Okram Barun, Nikulin Victor, Wang Xia, Choi Ha Soon, REID Scott W, November 22, 2007: WO/2007/134259 (12 worldwide citation)

The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal act ...


10
Albaugh Pamela, Chopiuk Gregory S, Ding Qiang, Huang Shenlin, Liu Zuosheng, Pan Shifeng, Ren Pingda, Wang Xia, Wang Xing, Xie Yongping, Zhang Chengzhi, Zhang Qiong, Zhang Guobao, Poon Daniel, Renhowe Paul, Sendzik Martin: Compounds and compositions as protein kinase inhibitors. Irm, Novartis, Albaugh Pamela, Chopiuk Gregory S, Ding Qiang, Huang Shenlin, Liu Zuosheng, Pan Shifeng, Ren Pingda, Wang Xia, Wang Xing, Xie Yongping, Zhang Chengzhi, Zhang Qiong, Zhang Guobao, Poon Daniel, Renhowe Paul, Sendzik Martin, REID Scott W, April 10, 2008: WO/2008/042639 (11 worldwide citation)

The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal act ...